Mechanistically, the cancer-preventive activity of silibinin was initially attributed to the reduced lung tumor expression of the angiogenic factor vascular endothelial growth factor (VEGF), mediated by the suppression of VEGF regulators such as cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) [34]. Here, PTGS2 is linked to cancer.